Ms. Brewer landed the job of Walgreens CEO in March 2021, previously serving as COO of coffee giant Starbucks.
Formerly, she held the title of CEO at Walmart’s Sam’s Club. Less than three years after her Walgreens appointment, Ms. Brewer and the board “mutually agreed” to part ways in September, according to the Dec. 26 report.
Under Ms. Brewer’s leadership, the health retail giant experienced an earnings target cut, struggles with staff shortages that cut back on pharmacy hours, and a declining stock price.
As of early December, Walgreens was the worst-performing stock in the Dow Jones Industrial Average for 2023.
It fell 48% over Ms. Brewer’s tenure, compared with a 5% fall for rival healthcare giant CVS during the same time period.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
